Orthodontics Market is Expected to Reach $8,370.5 Million by the end of 2030

The global orthodontics market is witnessing a significant decline in the size of the market due to the ongoing COVID-19 pandemic. The overall market was $5,681.1 million in FY2019, and it is expected to grow at a CAGR of 6.17% during the forecast period, 2021-2030. Presently, more than 50 companies are operating in this market, including the already existing and emerging medical device companies.

Owing to the COVID-19 pandemic, the secondary procedures, including dental and orthodontic procedures, were shut down, which, in turn, has caused the decline of the global orthodontics market in 2020. However, the impact of the pandemic is anticipated to be short-term, and with the resumption of secondary procedures, the global orthodontics market is projected to recover from 2021.

Key Questions Answered in this Report:

•   How has COVID-19 impacted the global orthodontics market?
•   How has the entry of start-ups impacted the global orthodontics market?
•   What is the treatment landscape for orthodontics conditions across various regions?
•   How do the attributes such as physician density, procedure volume, and payment landscape impact the orthodontics market across various geographic regions?
•   How has the digitization or introduction of technology altered the treatment landscape for the global orthodontics market?
•   Which companies are the leading players in the global orthodontics market, and what were their market shares in 2019?
•   What are the various synergistic activities employed by companies in the global orthodontics market?
•   What are the various marketing strategies employed by the companies to promote the sales of orthodontic devices?
•   How does the end-user perception impact the growth of the global orthodontics market?
•   What are the trends that are impacting the global orthodontics market? How has the partnership between healthcare and non-healthcare organizations impacted the growth of the market?
•   How is the patent landscape for the global orthodontics market? Who are the major market players that have filed for patents between January 2017 and mid-October 2020?
•   What are the various types of orthodontic products available in the market? What was their market share in 2019, and what will be the estimated market share for 2030?
•   How is the global orthodontics market anticipated to grow in emerging economies such as Asia-Pacific, Latin America, Middle East, and Africa

View Sample Report – https://bisresearch.com/requestsample?id=1015&type=download

Comments

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development. Impact Several techniques are employed in ...

Market Research Reports

Search This Blog